Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
The initiative aims to connect startups and tech companies with its business units,
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
This strategic initiative aims to accelerate proof-of-concept of pipeline assets by streamlining R&D operations
Consolidated revenue from operations stood at Rs. 111.05 crore
This remarkable increase from 17 in 2021 ranks among the fastest for pharmaceutical companies, establishing Lupin as a leader in sustainable growth
The successful refinancing and enhancement of the syndicated credit facilities provides access to an additional CHF 40 million
This partnership has led to a 10% boost in delivery speed
Subscribe To Our Newsletter & Stay Updated